Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Carcinocythemia with Microfilaria: Two Diverse Pathologies in One Case

Swagatika Samal, MBBS MD, Shruti Mishra, MBBS, MD PDF Hematology, Rasheeda Mohamedali, MBBS, Kishore Kumar, MBBS, MD DM

Blood (2019) 134 (Supplement_1): 4867.

https://doi.org/10.1182/blood-2019-131393

Published: 2019

Journal Articles

Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

Shyamala C. Navada, MD, Guillermo Garcia-Manero, MD, Ehab L. Atallah, MD, M. Nabeel Rajeh, MD, Jamile M. Shammo, MD, Elizabeth A. Griffiths, MD, Samer K. Khaled, MD, Shaker R. Dakhil, MD, David E. Young, MD, Rosalie Odchimar-Reissig, RN, Afoluso Ronnee Adesanya, MD, Patrick S. Zbyszewski, MBA, Richard C. Woodman, MD, Pierre Fenaux, MD PhD, Lewis R. Silverman, MD

Blood (2019) 134 (Supplement_1): 566.

https://doi.org/10.1182/blood-2019-131676

Published: 2019

Journal Articles

Addition of the SMO Inhibitor Sonidegib to Azacitidine in Patients with Higher Risk Myelodysplastic Syndrome (MDS) Who Failed to Respond or Lost Response to AZA Alone: Results of a Phase 1-2 Add-on Study By the GFM

Norbert Vey, MD PhD

Blood (2018) 132 (Supplement 1): 4368.

https://doi.org/10.1182/blood-2018-99-113529

Published: 2018

Journal Articles

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

Seung Lee, bs, Coby Palmares, Niko Koutsoukos, J. Brice Weinberg, MD, Trisa Palmares, MD, Alice Song, MD, Harold Song, MD, Sheila Benedicto, bs, Michael Song, bs, Vu Phan, MD, Julia Song, MD

Blood (2016) 128 (22): 5500.

https://doi.org/10.1182/blood.V128.22.5500.5500

Published: 2016

Journal Articles

Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Who Have Undergone Prior Allogeneic Stem Cell Transplant

Steven Coutre, MD, Susan O'Brien, MD, John C. Byrd, MD, Peter Hillmen, MB, ChB, PhD, Jennifer R. Brown, Martin JS Dyer, Anthony R. Mato, MD, David B. Miklos, Michael Keating, MBBS, Cathy Zhou, MS, Maria Fardis, PhD MBA, Lori Styles, MD, Samantha Jaglowski, MD MPH

Blood (2014) 124 (21): 4697.

https://doi.org/10.1182/blood.V124.21.4697.4697

Published: 2014

Journal Articles

Parenteral CoQ10 Formulation (BPM31510) Significantly Improves Survival In Animal Model Of Leukemia Including The Resolution Of Paraplegia Due To Brain Metastasis

Niven R Narain, Lucia M Mauro, Viatcheslav R Akmaev, PhD, Ely Benaim, MD, Rangaprasad Sarangarajan, PhD, Joaquin J Jimenez, MD

Blood (2013) 122 (21): 1457.

https://doi.org/10.1182/blood.V122.21.1457.1457

Published: 2013

Journal Articles

Spinal Artery Thrombosis: An Unrecognized Severe Complication in Thalassemia and Sickle Disorders

Maria Marzolini, Erika Poggiali, MD, Mohsin Badat, Elena Cassinerio, MD, Maria D Cappellini, John B. Porter, MD

Blood (2012) 120 (21): 1155.

https://doi.org/10.1182/blood.V120.21.1155.1155

Published: 2012

Journal Articles

A Phase 1 Trial of Escalating High Dose Methotrexate Supported by Glucarpidase to Treat Patients with Primary Central Nervous System Lymphoma (PCNSL). (CRUK/08/010)

Roderick J. Johnson, MD, Andrew Davies, MD, Siow-Ming Lee, MD, Dianne Gilson, MD, Paul Smith, PhD, Wendi Qian, Nivette Braganca, Nadjet El-mehidi, Peter Johnson

Blood (2012) 120 (21): 4850.

https://doi.org/10.1182/blood.V120.21.4850.4850

Published: 2012

Journal Articles

Defining Treatment Paradigms for BK Virus-Induced Hemorrhagic Cystitis in the Post-Allogeneic Hematopoietic Stem Cell Transplant Setting

Devi D Morrison, Samith Thomas Kochuparambil, David Deremer, Ethan Speir, Kristen Sterling, Meghan Sterrett, Vamsi Kota, MBBS, Anand P. Jillella, MD, Farrukh T Awan, MD, MS

Blood (2011) 118 (21): 4468.

https://doi.org/10.1182/blood.V118.21.4468.4468

Published: 2011

Journal Articles

Inotuzumab Ozogamicin (CMC-544) In Patients with Indolent B-Cell NHL That Is Refractory to Rituximab Alone, Rituximab and Chemotherapy, or Radioimmunotherapy: Preliminary Safety and Efficacy From a Phase 2 Trial

Andre Goy, MD, Joseph Leach, MD, W. Christopher Ehmann, MD, Kiyoshi Ando, MD, PhD, Kiyohiko Hatake, MD, PhD, Kensei Tobinai, MD, PhD, Tatyana Feldman, MD, Steven Hua, Angela DG Volkert, Erik R. Vandendries, MD, PhD, Michinori Ogura, MD, PhD

Blood (2010) 116 (21): 430.

https://doi.org/10.1182/blood.V116.21.430.430

Published: 2010

Journal Articles

Reduction of Urinary Bladder Activity in Transgenic Sickle Cell Disease Mice.

Mário Angelo Claudino, B.Sc., Ph.D, Carla Fernanda Franco-Penteado, B.Sc., M.Sc., Ph.D, Marcus A.F. Corat, B.Sc., M.Sc., Ph.D, Ana Paula Gimenes, B.Sc, Kleber Yotsumoto Fertrin, MD, Luiz Augusto C Passos, B.Sc., M.Sc., Ph.D, Edson Antunes, B.Sc., M.Sc., Ph.D, Fernando Ferreira Costa, Ph.D., M.D.

Blood (2009) 114 (22): 2580.

https://doi.org/10.1182/blood.V114.22.2580.2580

Published: 2009

Journal Articles

Incidence of Adenovirus and BK Virus Reactivation and Diseases Following Reduced-Intensity Cord Blood Transplantation for Adult Patients.

Kazuya Ishiwata, Naoyuki Uchida, Hisashi Yamamoto, Shinsuke Takagi, Daisuke Kato, Sachiko Seo, Naofumi Matsuno, Kazuhiro Masuoka, Atsushi Wake, Shigesaburo Miyakoshi, Akiko Yoneyama, Shuichi Taniguchi

Blood (2007) 110 (11): 1073.

https://doi.org/10.1182/blood.V110.11.1073.1073

Published: 2007

Journal Articles

Hypertensive Encephalopathy in Children with Sickle Cell Disease.

Caterina P. Minniti, MD, Steven L. Weinstein, MD, Zarir Khademian, MD

Blood (2005) 106 (11): 3790.

https://doi.org/10.1182/blood.V106.11.3790.3790

Published: 2005

NARROW

Carcinocythemia with Microfilaria: Two Diverse Pathologies in One Case

Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

Addition of the SMO Inhibitor Sonidegib to Azacitidine in Patients with Higher Risk Myelodysplastic Syndrome (MDS) Who Failed to Respond or Lost Response to AZA Alone: Results of a Phase 1-2 Add-on Study By the GFM

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

Safety and Efficacy of Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Who Have Undergone Prior Allogeneic Stem Cell Transplant

Parenteral CoQ10 Formulation (BPM31510) Significantly Improves Survival In Animal Model Of Leukemia Including The Resolution Of Paraplegia Due To Brain Metastasis

Spinal Artery Thrombosis: An Unrecognized Severe Complication in Thalassemia and Sickle Disorders

A Phase 1 Trial of Escalating High Dose Methotrexate Supported by Glucarpidase to Treat Patients with Primary Central Nervous System Lymphoma (PCNSL). (CRUK/08/010)

Defining Treatment Paradigms for BK Virus-Induced Hemorrhagic Cystitis in the Post-Allogeneic Hematopoietic Stem Cell Transplant Setting

Inotuzumab Ozogamicin (CMC-544) In Patients with Indolent B-Cell NHL That Is Refractory to Rituximab Alone, Rituximab and Chemotherapy, or Radioimmunotherapy: Preliminary Safety and Efficacy From a Phase 2 Trial

Reduction of Urinary Bladder Activity in Transgenic Sickle Cell Disease Mice.

Incidence of Adenovirus and BK Virus Reactivation and Diseases Following Reduced-Intensity Cord Blood Transplantation for Adult Patients.

Hypertensive Encephalopathy in Children with Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only